Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/16203
Title: Identity by descent fine mapping of familial adult myoclonus epilepsy (FAME) to 2p11.2-2q11.2
Authors: Henden, Lyndal;Freytag, Saskia;Afawi, Zaid;Baldassari, Sara;Berkovic, Samuel F;Bisulli, Francesca;Canafoglia, Laura;Casari, Giorgio;Crompton, Douglas E;Depienne, Christel;Gecz, Jozef;Guerrini, Renzo;Helbig, Ingo;Hirsch, Edouard;Keren, Boris;Klein, Karl Martin;Labauge, Pierre;LeGuern, Eric;Licchetta, Laura;Mei, Davide;Nava, Caroline;Pippucci, Tommaso;Rudolf, Gabrielle;Scheffer, Ingrid E;Striano, Pasquale;Tinuper, Paolo;Zara, Federico;Corbett, Mark A;Bahlo, Melanie
Issue Date: 1-Jul-2016
EDate: 2016-07-01
Citation: Human Genetics 2016; online first: 1 July
Abstract: Familial adult myoclonus epilepsy (FAME) is a rare autosomal dominant disorder characterized by adult onset, involuntary muscle jerks, cortical myoclonus and occasional seizures. FAME is genetically heterogeneous with more than 70 families reported worldwide and five potential disease loci. The efforts to identify potential causal variants have been unsuccessful in all but three families. To date, linkage analysis has been the main approach to find and narrow FAME critical regions. We propose an alternative method, pedigree free identity-by-descent (IBD) mapping, that infers regions of the genome between individuals that have been inherited from a common ancestor. IBD mapping provides an alternative to linkage analysis in the presence of allelic and locus heterogeneity by detecting clusters of individuals who share a common allele. Succeeding IBD mapping, gene prioritization based on gene co-expression analysis can be used to identify the most promising candidate genes. We performed an IBD analysis using high-density single nucleotide polymorphism (SNP) array data followed by gene prioritization on a FAME cohort of ten European families and one Australian/New Zealander family; eight of which had known disease loci. By identifying IBD regions common to multiple families, we were able to narrow the FAME2 locus to a 9.78 megabase interval within 2p11.2–q11.2. We provide additional evidence of a founder effect in four Italian families and allelic heterogeneity with at least four distinct founders responsible for FAME at the FAME2 locus. In addition, we suggest candidate disease genes using gene prioritization based on gene co-expression analysis.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16203
DOI: 10.1007/s00439-016-1700-8
ORCID: 0000-0002-1121-9513
0000-0003-4580-841X
0000-0002-7884-6861
0000-0002-2311-2174
0000-0001-5132-0774
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/27368338
Type: Journal Article
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.